Issued Patents All Time
Showing 1–25 of 26 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11370769 | TRPC5 inhibitors and methods of using same | Anna Greka | 2022-06-28 |
| 11180499 | Phosphodiesterase inhibitors | — | 2021-11-23 |
| 10745400 | Inhibition of BMP signaling, compounds, compositions and uses thereof | Matthew Ritter, Charles C. Hong, Anish K. Vadukoot, Darren W. Engers, Craig W. Lindsley | 2020-08-18 |
| 10710997 | Isoquinoline amide and isoquinoline amide-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Andrew S. Felts, Aaron M. Bender | 2020-07-14 |
| 10654847 | Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1 | Craig W. Lindsley, P. Jeffrey Conn, Michael R. Wood, Bruce J. Melancon, Michael S. Poslusney +1 more | 2020-05-19 |
| 10526323 | Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Darren W. Engers, Joe Panarese +3 more | 2020-01-07 |
| 10227343 | Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Joanne J. Bronson, Yong-Jin Wu +4 more | 2019-03-12 |
| 10221172 | Benzothiazole and benzisothiazole-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Darren W. Engers, Sean R. Bollinger | 2019-03-05 |
| 10196392 | Fused heterocyclic compounds as selective BMP inhibitors | Charles C. Hong, Craig W. Lindsley, Darren W. Engers | 2019-02-05 |
| 9980945 | Benzoisoxazole-substituted compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Darren W. Engers, Joe Panarese +2 more | 2018-05-29 |
| 9738636 | Fused heterocyclic compounds as selective BMP inhibitors | Charles C. Hong, Craig W. Lindsley, Darren W. Engers | 2017-08-22 |
| 9586964 | Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1 | Craig W. Lindsley, P. Jeffrey Conn, Michael R. Wood, Bruce J. Melancon, Michael S. Poslusney +1 more | 2017-03-07 |
| 9192603 | Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Rocco D. Gogliotti, James M. Salovich +2 more | 2015-11-24 |
| 9180192 | mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Rocco D. Gogliotti | 2015-11-10 |
| 9163015 | Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Rocco D. Gogliotti, James M. Salovich +2 more | 2015-10-20 |
| 9108963 | Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Rocco D. Gogliotti, James M. Salovich +2 more | 2015-08-18 |
| 9073935 | Substituted benzylspiroindolin-2-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1 | Craig W. Lindsley, P. Jeffrey Conn, Michael R. Wood, Bruce J. Melancon, Michael S. Poslusney | 2015-07-07 |
| 9056876 | Substituted 1H-pyrazolo[3′,4′,4,5]thieno[2,3-b]pyridin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4 | Jeffrey P. Conn, Craig W. Lindsley, Michael R. Wood, James M. Salovich, Bruce J. Melancon | 2015-06-16 |
| 9040694 | Compounds and methods useful for directing stem cell differentiation | Charles C. Hong, Antonis K. Hatzopoulos, Craig W. Lindsley, Jijun Hao | 2015-05-26 |
| 8916584 | Benzisoxazoles and azabenzisoxazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Darren W. Engers | 2014-12-23 |
| 8912336 | Aryl and heteroaryl sulfones as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Charles David Weaver, Colleen M. Niswender, Yiu-Yin Cheung | 2014-12-16 |
| 8822684 | Compounds and methods useful for directing stem cell differentiation | Charles C. Hong, Antonis K. Hatzopoulos, Craig W. Lindsley, Jijun Hao | 2014-09-02 |
| 8779157 | MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Charles David Weaver, Colleen M. Niswender, Darren W. Engers +4 more | 2014-07-15 |
| 8759377 | Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Charles David Weaver, Colleen M. Niswender, Darren W. Engers | 2014-06-24 |
| 8658650 | Substituted 1,1,3,1-tetraoxidobenzo[D][1,3,2]dithiazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | P. Jeffrey Conn, Craig W. Lindsley, Charles David Weaver, Colleen M. Niswender, Rocco D. Gogliotti +1 more | 2014-02-25 |